tiprankstipranks
GlaxoSmithKline (GSK)
NYSE:GSK
Holding GSK?
Track your performance easily

GlaxoSmithKline (GSK) Technical Analysis

4,790 Followers

Technical Sentiment

Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
GlaxoSmithKline’s (GSK) Moving Averages Convergence Divergence (MACD) indicator is -1.32, suggesting GlaxoSmithKline is a Buy.
GlaxoSmithKline’s (GSK) 20-Day exponential moving average is 35.44, while GlaxoSmithKline’s (GSK) share price is $33.7, making it a Sell.
GlaxoSmithKline’s (GSK) 50-Day exponential moving average is 37.34, while GlaxoSmithKline’s (GSK) share price is $33.7, making it a Sell.

GlaxoSmithKline (GSK) Pivot Points

Nov 21, 2024, 05:29 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
32.89
33.06
33.26
33.43
33.63
33.80
34.00
Fibonacci
33.06
33.20
33.29
33.43
33.57
33.66
33.80
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

GlaxoSmithKline (GSK) Moving Averages

Nov 21, 2024, 05:29 PM
Period
Simple
Exponential
MA5
33.57Sell
33.74Sell
MA10
34.58Sell
34.40Sell
MA20
35.68Sell
35.44Sell
MA50
38.06Sell
37.34Sell
MA100
39.07Sell
38.52Sell
MA200
40.04Sell
38.90Sell
GlaxoSmithKline’s (GSK) 10-Day exponential moving average is 34.40, while GlaxoSmithKline’s (GSK) share price is $33.7, making it a Sell.
GlaxoSmithKline’s (GSK) 100-Day exponential moving average is 38.52, while GlaxoSmithKline’s (GSK) share price is $33.7, making it a Sell.
GlaxoSmithKline’s (GSK) stock price is $33.7 and GlaxoSmithKline’s (GSK) 50-day simple moving average is 38.06, creating a Sell signal.
GlaxoSmithKline’s (GSK) stock price is $33.7 and GlaxoSmithKline’s (GSK) 100-day simple moving average is 39.07, creating a Sell signal.
GlaxoSmithKline’s (GSK) stock price is $33.7 and GlaxoSmithKline’s (GSK) 200-day simple moving average is 40.04, creating a Sell signal.

GlaxoSmithKline (GSK) Technical Indicators

Nov 21, 2024, 05:29 PM
Name
Value
Implied Action
RSI (14)
25.59
Buy
STOCH (9,6)
17.24
Buy
STOCHRSI (14)
14.14
Buy
MACD (12,26)
-1.32
Buy
ADX (14)
31.13
Neutral
Williams %R
-89.01
Buy
CCI (14)
-131.00
Buy
ATR (14)
0.77
-
Ultimate Oscillator
14.78
Sell
ROC
-8.25
Sell
GlaxoSmithKline’s (GSK) Relative Strength Index (RSI) is 25.59, creating a Buy signal.
GlaxoSmithKline’s (GSK) Trend Strength Indicator (ADX) is 31.13, creating a Neutral signal.
GlaxoSmithKline’s (GSK) Commodity Channel Index (CCI) is -131.00, creating a Buy signal.
GlaxoSmithKline’s (GSK) Price Rate of Change (ROC) is -8.25, creating a Sell signal.

FAQ

Is GSK a Buy, Hold, or Sell?
Based on GSK’s technical indicators, GSK is a Sell.
    What is GSK’s RSI (14)?
    GSK’s RSI (14) is 25.59, which suggests GSK is a Buy.
      What is GSK’s MACD?
      GSK’s MACD is -1.32, which suggests GSK is a Buy.
        What is GSK’s 5-day moving average?
        GSK’s 5-day moving average is 33.57, which suggests GSK is a Sell.
          What is GSK’s 20-day moving average?
          GSK 20-day moving average is 35.68, which suggests GSK is a Sell.
            What is GSK’s 50-day moving average?
            GSK’s 50-day moving average is 38.06, which suggests GSK is a Sell.
              What is GSK’s 200-day moving average?
              GSK’s 200-day moving average is 40.04, which suggests GSK is a Sell.
                What is GSK’s Williams % R (14)?
                GSK’s Williams % R (14) is -89.01, which suggests GSK is a Buy.
                  What is GSK’s CCI (14)?
                  GSK’s CCI (14) is -131.00, which suggests GSK is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis